Madrigal Pharmaceuticals IncNASDAQ:MDGL
- LAST PRICE208.4100
- TODAY'S CHANGE (%)1.8300 (0.8859%)
- Bid / Lots205.0000/ 1
- Ask / Lots210.3800/ 1
- Open / Previous Close207.6900 / 206.5800
- Day Range
- 52 Week Range
- Volume256,650
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MDGL |
|---|---|---|
| 09:32 ET | 1610 | 209.71 |
| 09:34 ET | 367 | 209.64 |
| 09:36 ET | 223 | 208.645 |
| 09:38 ET | 570 | 210.03 |
| 09:41 ET | 150 | 209.526 |
| 09:43 ET | 600 | 208.935 |
| 09:45 ET | 300 | 209.19 |
| 09:48 ET | 200 | 209.9799 |
| 09:50 ET | 900 | 208.415 |
| 09:52 ET | 800 | 208.31 |
| 09:54 ET | 2600 | 208.315 |
| 09:57 ET | 100 | 207.62 |
| 09:59 ET | 100 | 206.6504 |
| 10:01 ET | 800 | 207.235 |
| 10:03 ET | 210 | 207.95 |
| 10:06 ET | 3310 | 207.48 |
| 10:08 ET | 300 | 207.725 |
| 10:10 ET | 240 | 207.485 |
| 10:12 ET | 1545 | 207.485 |
| 10:14 ET | 405 | 207.29 |
| 10:15 ET | 1300 | 206.42 |
| 10:19 ET | 100 | 206.92 |
| 10:30 ET | 3000 | 206.345 |
| 10:35 ET | 200 | 206.375 |
| 10:39 ET | 500 | 206.85 |
| 10:42 ET | 1000 | 206.85 |
| 10:44 ET | 4200 | 206.54 |
| 10:46 ET | 100 | 206.385 |
| 10:48 ET | 300 | 206.555 |
| 10:51 ET | 551 | 207.51 |
| 10:53 ET | 100 | 207.6 |
| 11:02 ET | 100 | 207.995 |
| 11:06 ET | 100 | 208.41 |
| 11:11 ET | 150 | 208.39 |
| 11:15 ET | 3089 | 209.28 |
| 11:18 ET | 300 | 209.0099 |
| 11:22 ET | 100 | 208.35 |
| 11:24 ET | 1100 | 207.96 |
| 11:31 ET | 100 | 207.72 |
| 11:33 ET | 900 | 206.7 |
| 11:36 ET | 100 | 206.96 |
| 11:40 ET | 391 | 207.65 |
| 11:45 ET | 700 | 207.335 |
| 11:47 ET | 200 | 207.33 |
| 11:51 ET | 100 | 206.87 |
| 11:56 ET | 100 | 206.7 |
| 12:00 ET | 100 | 206.6 |
| 12:03 ET | 200 | 207.81 |
| 12:05 ET | 210 | 207.67 |
| 12:07 ET | 749 | 207.66 |
| 12:09 ET | 264 | 207.645 |
| 12:12 ET | 500 | 207.59 |
| 12:14 ET | 100 | 208 |
| 12:16 ET | 100 | 208.33 |
| 12:18 ET | 1900 | 208.26 |
| 12:20 ET | 2522 | 208 |
| 12:23 ET | 801 | 207.895 |
| 12:25 ET | 691 | 207.9 |
| 12:27 ET | 900 | 207.91 |
| 12:30 ET | 100 | 208 |
| 12:32 ET | 100 | 207.83 |
| 12:34 ET | 500 | 208 |
| 12:45 ET | 208 | 208.05 |
| 12:50 ET | 1100 | 208.04 |
| 12:52 ET | 200 | 208.255 |
| 12:54 ET | 800 | 208.07 |
| 12:56 ET | 100 | 208.07 |
| 12:57 ET | 250 | 207.95 |
| 12:59 ET | 1800 | 207.9 |
| 01:01 ET | 1500 | 207.7 |
| 01:03 ET | 200 | 207.665 |
| 01:08 ET | 118 | 207.77 |
| 01:10 ET | 300 | 208 |
| 01:12 ET | 454 | 207.93 |
| 01:14 ET | 948 | 208.02 |
| 01:15 ET | 500 | 208.16 |
| 01:19 ET | 100 | 208.325 |
| 01:21 ET | 2150 | 207.84 |
| 01:24 ET | 200 | 208.13 |
| 01:26 ET | 200 | 208.34 |
| 01:30 ET | 100 | 208.315 |
| 01:32 ET | 402 | 207.98 |
| 01:33 ET | 100 | 208.25 |
| 01:35 ET | 100 | 208.19 |
| 01:37 ET | 1600 | 207.03 |
| 01:39 ET | 1000 | 207.683793 |
| 01:42 ET | 1000 | 207.05 |
| 01:44 ET | 500 | 207.17 |
| 01:46 ET | 2500 | 206.77 |
| 01:48 ET | 200 | 206.62 |
| 01:50 ET | 1000 | 206.58 |
| 01:51 ET | 100 | 206.46 |
| 01:53 ET | 200 | 206.04 |
| 01:55 ET | 100 | 206.04 |
| 02:02 ET | 300 | 205.97 |
| 02:04 ET | 100 | 205.87 |
| 02:06 ET | 200 | 206.65 |
| 02:08 ET | 300 | 207.21 |
| 02:09 ET | 100 | 207.23 |
| 02:11 ET | 100 | 206.97 |
| 02:18 ET | 100 | 207.32 |
| 02:24 ET | 100 | 207.5 |
| 02:26 ET | 100 | 207.83 |
| 02:27 ET | 500 | 208.01 |
| 02:29 ET | 1093 | 207.71 |
| 02:31 ET | 100 | 207.59 |
| 02:33 ET | 540 | 207.19 |
| 02:36 ET | 400 | 207.15 |
| 02:38 ET | 430 | 207.11 |
| 02:42 ET | 200 | 207.55 |
| 02:44 ET | 300 | 207.98 |
| 02:45 ET | 200 | 207.88 |
| 02:47 ET | 200 | 207.7 |
| 02:49 ET | 2417 | 207.2 |
| 02:51 ET | 2726 | 207.07 |
| 02:54 ET | 4000 | 207.295 |
| 02:56 ET | 1400 | 207.59 |
| 02:58 ET | 500 | 207.75 |
| 03:00 ET | 400 | 207.92 |
| 03:02 ET | 1804 | 208.06 |
| 03:03 ET | 300 | 208.005 |
| 03:05 ET | 500 | 208.005 |
| 03:07 ET | 500 | 208.12 |
| 03:09 ET | 753 | 208.29 |
| 03:12 ET | 100 | 208.255 |
| 03:14 ET | 5431 | 208.17 |
| 03:16 ET | 554 | 208.29 |
| 03:18 ET | 600 | 208.28 |
| 03:20 ET | 100 | 208.93 |
| 03:21 ET | 100 | 208.83 |
| 03:23 ET | 482 | 208.8 |
| 03:25 ET | 1300 | 208.615 |
| 03:27 ET | 200 | 208.72 |
| 03:30 ET | 200 | 208.72 |
| 03:34 ET | 2473 | 208.66 |
| 03:36 ET | 300 | 208.555 |
| 03:38 ET | 1000 | 208.665 |
| 03:39 ET | 100 | 208.975 |
| 03:41 ET | 200 | 209.005 |
| 03:43 ET | 1626 | 208.595 |
| 03:45 ET | 300 | 208.5 |
| 03:48 ET | 1200 | 208.43 |
| 03:50 ET | 500 | 208.5 |
| 03:52 ET | 600 | 208.61 |
| 03:54 ET | 2025 | 208.58 |
| 03:56 ET | 4094 | 208.58 |
| 03:57 ET | 3157 | 208.33 |
| 03:59 ET | 27319 | 208.41 |
Oct 2, 2024
Madrigal Pharmaceuticals to Participate in the H.C. Wainwright & Co. 8th Annual MASH Investor Conference, from 8:00AM ET on Wednesday Oct 02, 2024 by Dow Jones
8:00AM ET on Wednesday Oct 02, 2024 by Dow Jones
Oct 1, 2024
Madrigal Pharmaceuticals Appoints Dr. Michael R. Charlton as Senior Vice President, Clinical Development, from 8:01AM ET on Tuesday Oct 01, 2024 by Dow Jones
8:01AM ET on Tuesday Oct 01, 2024 by Dow Jones
Sep 30, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Madrigal Pharmaceuticals Inc | 4.5B | -8.2x | --- |
Immunovant Inc | 4.5B | -15.9x | --- |
Biohaven Ltd | 4.7B | -5.2x | --- |
BridgeBio Pharma Inc | 4.7B | -9.6x | --- |
Crinetics Pharmaceuticals Inc | 4.3B | -14.1x | --- |
Krystal Biotech Inc | 5.1B | 48.5x | --- |
Company Information
Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH). The Company's product candidate, resmetirom, is a once-daily, oral, liver-directed thyroid hormone receptor-β (THR-β) agonist designed to target key underlying causes of NASH. NASH is a more advanced form of non-alcoholic fatty liver disease (NAFLD). The Company’s clinical development program includes MAESTRO-NASH, MAESTRO-NAFLD-1, and MAESTRO-NASH OUTCOMES.
Contact Information
- Headquarters
- 200 Barr Harbor Dr Ste 400WEST CONSHOHOCKEN, PA, United States 19428-2978
- Phone
- 404-380-9263
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Julian Baker
- President, Chief Executive Officer, Director
- Bill Sibold
- Chief Financial Officer, Senior Vice President
- Mardi Dier
- President of Research and Development, Chief Medical Officer, Director
- Rebecca Taub
- Senior Vice President - Clinical Development
- Michael Charlton
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.5B |
|---|---|
Revenue (TTM) | $14.6M |
Shares Outstanding | 21.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.44 |
EPS | $-25.50 |
Book Value | $20.39 |
P/E Ratio | -8.2x |
Price/Sales (TTM) | 309.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -3,622.65% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
